Xbrane Biopharma: Ximluci Approved in the EU
Research Note
2022-11-11
09:43
Redeye leaves a short comment on today’s news that Xbrane and STADA have secured EU approval for Ximluci. Today’s announcement was expected, but it nevertheless marks a significant milestone for the company, and the Q1 2023 launch is nearing swiftly.
Filip Einarsson
Disclosures and disclaimers